|
|
Article: BRIEFING - ASIA HEALTH - MARCH 4, 2009.
- Article from:
- AsiaPulse News
- Article date:
- March 4, 2009
CopyrightCOPYRIGHT 2009 Asia Pulse Pty Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
An executive briefing on Health for March 4, 2009, prepared by Asia Pulse (http://www.asiapulse.com), the real-time, Asia-based wire with exclusive news, commercial intelligence and business opportunities.
JAPAN'S SHIONOGI TARGETS APPROVAL FOR NEW FLU DRUG BY MARCH '10
TOKYO - Japan's Shionogi & Co. (TSE:4507) has completed the drug administration portion of Phase III clinical trials for the influenza drug "Peramivir" it is developing.
The company is now hurrying to analyze the data produced by the trials, with the aim of seeking approval for the drug in Japan during fiscal 2009.
CHINA'S MOC ALLOWS HK, MACAO AS SOLE TRADERS IN ...